⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ANIX News
Anixa Biosciences, Inc.
Anixa Biosciences Featured on Water Tower Research Healthcare Happenings Podcast
prnewswire.com
ANIX
Form 8-K
sec.gov
ANIX
Anixa Biosciences Receives Notice of Allowance from Korean Ministry of Intellectual Property (MOIP) for Patent Covering Breast Cancer Vaccine Technology
prnewswire.com
ANIX
Anixa Biosciences to Host 2026 Annual Meeting of Stockholders and Provide Corporate Update Highlighting Recent Clinical and Regulatory Progress
prnewswire.com
ANIX
Anixa Biosciences Announces Dr. Jose Conejo-Garcia will Keynote the South Carolina Clinical & Translational Research Institute 2026 Retreat
prnewswire.com
ANIX
Anixa Biosciences Secures United States Adopted Names Council Approval of Non-Proprietary Name for its CAR-T Therapy, a Key Step Toward Future Commercialization
prnewswire.com
ANIX
Anixa Biosciences Receives Notice of Allowance from Mexican Institute of Industrial Property (IMPI) for Patent Covering Breast Cancer Vaccine Technology
prnewswire.com
ANIX
Anixa Biosciences Announces Transfer of IND for Breast Cancer Vaccine from Cleveland Clinic
prnewswire.com
ANIX
Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants
prnewswire.com
ANIX
Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025
prnewswire.com
ANIX